BUSINESS ADVISORY AGREEMENTBusiness Advisory Agreement • May 20th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
This Agreement is made and entered into as of this 1st day of April, 2008 (the “Effective Date”) between XenaCare Holdings, Inc., a Florida corporation with offices at 14000 North Military Trail, Suite 104, Delray Beach, Florida 33484 (the “Company” or “XENA”) and Newbridge Securities Corporation, a Virginia corporation with its principal offices at 1451 West Cypress Creek Road, Suite 204, Fort Lauderdale, Florida 33309 (the “Advisor”).
SETTLEMENT AND RELEASE AGREEMENTSettlement and Release Agreement • November 26th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
This Settlement and Release Agreement (the “Agreement”) is entered into this 5th day of November 2008 by and between Xenacare Holdings, Inc., (“XCH” or “Debtor”) and FLORIDA CARTOON COLLECTORS, INC., a creditor of the Company (Creditor”).
SETTLEMENT AND RELEASE AGREEMENTSettlement Agreement • November 26th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
This Settlement and Release Agreement (the “Agreement”) is entered into this 5th day of November 2008 by and between Xenacare Holdings, Inc., (“XCH” or “Debtor”) and FLORIDA-AMERICAN, INC., a creditor of the Company (Creditor”).
CONSULTING AGREEMENTConsulting Agreement • April 15th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances)
THIS CONSULTING AGREEMENT (“Agreement”) is made as of October 1, 2007 between XENACARE HOLDINGS, INC., a Florida corporation (the “Company”), and INTERACTIVE BUSINESS DEVELOPMENT, INC., a corporation the (“Consultant”).
Exclusive Territory Distribution AgreementExclusive Territory Distribution Agreement • November 16th, 2009 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
This agreement (the “Agreement”) is entered into as of May 29, 2009 (the “Effective Date”), by and between Mineral Sciences, LLC (hereinafter known as “MSI”) with principal offices located at, 7915 NW 111th Way, Parkland, FL 33076. and XenaCare Holdings (hereinafter known as “XenaCare”) with principal offices located at 14000 Military Trail, Suite 104, Delray Beach, Florida, 33484. The parties are sometimes referred to collectively herein as the “Parties” and individually as a “Party.”
TERMINATION AND SETTLEMENT AGREEMENTTermination and Settlement Agreement • November 26th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
THIS TERMINATION AND SETTLEMENT (“Agreement”) dated this 20th day of November, 2008, is by and between Gary Spaniak, Sr.(“Spaniak”) and XENACARE HOLDINGS, INC (“XHI”).
EXHIBIT 10.2 LICENSING AGREEMENT This Licensing Agreement ("Agreement") is made on this 24th day of February 2006, between Scientific Sports Nutrition (hereinafter referred to as "SSN"), located at 225 Long Ave Hillside NJ 07205 and Xenacare Holdings...Licensing Agreement • December 22nd, 2006 • Xenacare Holdings, Inc. • New Jersey
TERMINATION AND SETTLEMENT AGREEMENTTermination and Settlement Agreement • November 24th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
THIS TERMINATION AND SETTLEMENT (“Agreement”) dated this 10th day of December, 2007, is by and between CONNIED, INC., its affiliates, subsidiaries, principals and predecessors (collectively, “CONNIED”) and XENACARE HOLDINGS, INC (“XHI”).
CONSULTING AGREEMENTConsulting Agreement • November 24th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances)
THIS CONSULTING AGREEMENT ("Agreement") is made as of May 26, 2005 between XENACARE MANAGEMENT, LLC (“XENACARE” or the "Company"), a corporation under the laws of the State of Florida, and CONNIED, INC., a corporation under the laws of the State of Florida (the "Consultant").
EMPLOYMENT AGREEMENTEmployment Agreement • September 25th, 2007 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
THIS EMPLOYMENT AGREEMENT (“Agreement”) is made and effective as of January 1, 2007 between XENACARE HOLDINGS INC., a Florida corporation the “Corporation”), and ALAN XENAKIS, MD, an individual (“Executive”).
AGREEMENT WITH ________________________________________ (XRN)Employment Agreement • February 23rd, 2007 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
THIS AGREEMENT made this _________________ between XENASTAFF, LLC, A WHOLLY OWNED SUBSIDIARY OF XENACARE HOLDINGS, INC., having a principal place of business at 3275 West Hillsboro Blvd, Suite 300, Deerfield Beach, Florida 33442, hereinafter referred to as the EMPLOYER, and ___________________ a registered nurse, having a principle domicile at ____________________ hereinafter referred to as the XRN.
Employment AgreementEmployment Agreement • September 25th, 2007 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances)
THIS Employment AGREEMENT (“Agreement”) is made as of January 1, 2007 between XENACARE HOLDINGS, INC., a Florida corporation (the “Company”), and Frank Rizzo, an individual (the “Employee”) as President.
ASSIGNMENT OF CONSULTING CONTRACTAssignment of Consulting Contract • November 24th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances)
Upon the re-organization of Xenacare Management , LLC.. a Delaware corporation on June 5. 2005 the company hereby assigns to Xenacare Holdings, Inc.. a Florida corporation a certain consulting contract dated May 26, 2005 between Xenacare Management. LLC and Connied. Inc.. a Florida corporation. All parties mutually agree to the assignment of the Consulting contract in its entirety as written and signed.
PUBLIC EDUCATOR SPOKESPERSON AGREEMENTPublic Educator Spokesperson Agreement • September 25th, 2007 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
This Public Educator Spokesperson Agreement (the “Agreement”) is entered into and effective as of February 15, 2007 (the “Effective Date”) by and between Xenacare Inc. (“XEN”) and Bob Arnot (“Spokesperson”). The parties hereby agree as follows:
DEFINITIVE OUTPUT AGREEMENTDefinitive Output Agreement • September 25th, 2007 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Arizona
This DEFINITIVE OUTPUT AGREEMENT (the “Agreement”) is dated as of January 30, 2007 (the “Effective Date”) by and between ALGAL TECHNOLOGIES, INC., an Arizona corporation, located at P.O. Box 1509, Overgaard, Arizona 85933 (“Algal”), and RAW MATERIAL, INC., a Nevada corporation a division of XenaCare Holdings, Inc., located at 3725 W. Hillsboro Blvd., Deerfield Beach, Florida 33442 (“RMI”).
TERMINATION AND SETTLEMENT AGREEMENTTermination and Settlement Agreement • November 26th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
THIS TERMINATION AND SETTLEMENT (“Agreement”) dated this 20th day of November, 2008, is by and between Interactive Business Development, LLC. (“IBD”) and XENACARE HOLDINGS, INC (“XHI”).
CONSULTING AGREEMENTConsulting Agreement • November 19th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances)
THIS LIMITED PURPOSE CONSULTING AGREEMENT ("Agreement") is made as of August 21, 2008 between XENACARE HOLDINGS, INC. (the "Company"), and MARTIN HODIAS, (the "Consultant").
AMENDMENT OF SALES AGREEMENTSales Agreement • August 19th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances)
The undersigned hereby amend the Sales Agreement entered into by and between Xenacare Holdings, Inc. and Pure Laboratories, LLC on April 11, 2008, as follows:
ASSET PURCHASE AGREEMENT BETWEEN Beta Pharmaceutical Corp. AND Xenacare Holdings, Inc. a Florida corporation DATED October 30, 2007Asset Purchase Agreement • November 19th, 2007 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
This ASSET PURCHASE AGREEMENT (the “Agreement“) is made and entered into as of this 30th day of October, 2007 by and between XenaCare Holdings, Inc. a Florida corporation and its assigns (“PURCHASER”), and Beta Pharmaceutical Corp., a Florida corporation (“Seller”), together “the Parties.”
Exclusive Territory Distribution AgreementExclusive Territory Distribution Agreement • November 16th, 2009 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
This agreement (the “Agreement”) is entered into as of May 26, 2009 (the “Effective Date”), by and between Nutra Pharma Corporation (hereinafter known as “Nutra”) with principal offices located at, 791 Park of Commerce Blvd, Suite 300, Boca Raton, Florida, 33487. and XenaCare Holdings (hereinafter known as “XenaCare”) with principal offices located at 14000 Military Trail, Suite 104, Delray Beach, Florida, 33484. The parties are sometimes referred to collectively herein as the “Parties” and individually as a “Party.”
SALES AGREEMENTSales Agreement • May 20th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Florida
THIS AGREEMENT (the “Sales Agreement”) is made as of April 23, 2008 by and between Xenacare Holdings, Inc., a Florida corporation having a principal place of business of 14000 Military Trail, Suite 104, Delray Beach, Florida 33484 on the one hand (the “Purchaser”), and Pure Laboratories, LLC, a Florida limited liability company having a principal place of business of 8100 S.W. 81st Drive, Suite 210, Miami, Florida 33143 (the “Company”), on the other hand. Unless otherwise provided, capitalized terms used herein are defined in Article 4 below.
XenaCare Holdings Inc. Suite 3208 – 7700 Congress Avenue Boca Raton, FL Attention: Frank Rizzo Re: SierraSil Marketing Agreement Dear Sirs and Mesdames Sierra Mountain Minerals, Inc. (the "Company") is pleased to submit this letter agreement (the...Marketing Agreement • February 23rd, 2007 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • British Columbia
This Agreement is intended to be a valid legal agreement between the Parties, documenting the agreement between the Company and the Consultant.
SHARE EXCHANGE AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG XENACARE HOLDINGS, INC., SUN PACKING, INC., WALLISVILE PARTNERS, LTD. AND JON L. GROSSMAN AND PETER R. ELSTONShare Exchange Agreement • August 14th, 2008 • Xenacare Holdings, Inc. • Biological products, (no disgnostic substances) • Texas
This SHARE EXCHANGE AGREEMENT AND PLAN OF REORGANIZATION (this “Agreement”) is entered into on the 29th day of July, 2008 by and among XENACARE HOLDINGS, INC., a Florida corporation (“XCHO”); SUN PACKING, INC., a Texas corporation (“Sun”); WALLISVILLE PARTNERS, LTD., a Texas limited partnership (“Wallisville”); and JON L. GROSSMAN and PETER R. ELSTON (the “Shareholders”).
